Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2010
02/11/2010US20100035973 Disruption of programmed death 1 (pd-1) ligand to adjuvant adeno-associated virus vector vaccines
02/11/2010US20100035972 Oligonucleotide and use thereof
02/11/2010US20100035965 Sirna inhibition of p13k p85, pa110, and akt2 and methods of use
02/11/2010US20100035964 Antisense modulation of connective tissue growth factor expression
02/11/2010US20100035963 Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease
02/11/2010US20100035960 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040
02/11/2010US20100035813 Recombinant e-selectin made in insect cells
02/11/2010US20100035812 Modified Bovine G-CSF Polypeptides And Their Uses
02/11/2010US20100035807 Composition and method for treatment of tumors
02/11/2010US20100035806 Compositions and Methods for Detection and Modulation of T Cell Mediated Immune Responses Against Viral Vectors Utilized for Gene Therapy
02/11/2010US20100035804 Polypeptide antagonist
02/11/2010US20100035787 Compositions and Uses for an Alpha-Amylase Polypeptide of Bacillus Species 195
02/11/2010US20100035770 Methods and compositions for preparing rna from a fixed sample
02/11/2010US20100035767 Polymerase
02/11/2010US20100035760 Nucleic Acid molecules and Collections Thereof, Their Application and Modification
02/11/2010US20100035758 Method for detecting oral squamous-cell carcinoma
02/11/2010US20100035362 Bio-silica chip comprising silica binding protein and method for fabricating the same
02/11/2010US20100035347 Method for increasing the survival of bacterial strains of the rhizobium genus
02/11/2010US20100035346 Single protein production in living cells facilitated by a messenger rna interferase
02/11/2010US20100035345 High Production System for Infectious Hepatitis C Virus Particle
02/11/2010US20100035340 Variants of human taste receptor genes
02/11/2010US20100035329 recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts converts hydroxymethylglutaryl-CoA to mevalonic acid, mevalonic acid to phosphomevalonic acid, phosphomevalonic acid to phosphomevalonate, phosphomevalonate to isopentenyl pyrophosphate
02/11/2010US20100035320 Methods and compositions for improving the production of products in microorganisms
02/11/2010US20100035317 Novel alcohol dehydrogenase, gene for the alcohol dehydrogenase, vector, transformant, and method for production of optically active alcohol by using them
02/11/2010US20100035313 Microorganism capable of producing polyhydroxyalkanoate, polyhydroxyalkanoate synthase, and gene encoding the same
02/11/2010US20100035310 Production of Functional Proteins: Balance of Shear Stress and Gravity
02/11/2010US20100035307 Methionine Synthases with Reduced Product Inhibition
02/11/2010US20100035306 Fermentation of pentose sugars
02/11/2010US20100035301 Beta-mannanase from coffee berry borer, hypothenemus hampei, and uses thereof
02/11/2010US20100035280 Chimeric Fc-gamma Receptor and Method for Determination of ADCC Activity by Using the Receptor
02/11/2010US20100035262 Method for detecting thyroid carcinoma
02/11/2010US20100035256 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
02/11/2010US20100035241 Isolation Of Allergen-Specific Immunoglobulin Genes From Human B-Cells From Atopy Sufferers
02/11/2010US20100035237 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
02/11/2010US20100035236 Enrichment method for variant proteins with altered binding properties
02/11/2010US20100035229 Methods, plasmid vectors and primers for assessing hiv viral fitness
02/11/2010US20100034953 Genetically modified plants which synthesize a starch having increased swelling power
02/11/2010US20100034952 Novel melon plants
02/11/2010US20100034924 Bacterium
02/11/2010US20100034849 Recombinant Bicistronic Flavivirus Vectors
02/11/2010US20100034846 Novel method for treating h.pylori infections
02/11/2010US20100034845 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
02/11/2010US20100034841 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm
02/11/2010US20100034834 Modified t cell receptors and related materials and methods
02/11/2010US20100034826 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
02/11/2010US20100034814 Compositions and methods for binding lysophosphatidic acid
02/11/2010US20100034809 Compositions and Methods for Antibodies Targeting Complement Protein C5
02/11/2010US20100034776 Replication-competent anti-cancer vectors
02/11/2010US20100034775 RECOMBINANT ADENOVIRUS COMPRISING RECOMBINANT khp53 GENE AND THE PREPARATION METHOD AND USES THEREOF
02/11/2010US20100034774 Serotype of adenovirus and uses thereof
02/11/2010DE10336177B4 Verwendung von Zellorganellen zur Stabilisierung von Nukleinsäuren und Zellen Use of cell organelles for the stabilization of nucleic acids and cells
02/11/2010CA2733589A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
02/11/2010CA2733461A1 Methods of predicting cancer lethality using replikin counts
02/11/2010CA2733425A1 Vaccines against clostridium difficile and methods of use
02/11/2010CA2733267A1 Plant anti-pathogen systems
02/11/2010CA2733223A1 Pharmaceutical composition for treatment and prevention of cancers
02/11/2010CA2733204A1 Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof
02/11/2010CA2733142A1 Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof
02/11/2010CA2733104A1 Optimized promoter sequence
02/11/2010CA2733075A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
02/11/2010CA2733059A1 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides
02/11/2010CA2733057A1 Modulation of toll-like receptor 3 expression by antisense oligonucleotides
02/11/2010CA2732980A1 Method for detecting cancer
02/11/2010CA2732802A1 Modulation of toll-like receptor 8 expression by antisense oligonucleotides
02/11/2010CA2732799A1 Modulation of toll-like receptor 7 expression by antisense oligonucleotides
02/11/2010CA2732449A1 Fgfr extracellular domain acidic region muteins
02/11/2010CA2732283A1 Immunity-inducing agent
02/11/2010CA2732102A1 Radioprotectants targeting thrombospondin-1 and cd47
02/10/2010EP2151507A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
02/10/2010EP2151498A2 Expression cassettes for seed-preferential expression in plants
02/10/2010EP2151497A2 Chimeric U2 snRNA molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications
02/10/2010EP2151496A1 Method for evaluation of drug sensitivity by analysis of pomc gene
02/10/2010EP2151495A1 Hcv gene
02/10/2010EP2151494A2 Maltogenic alpha-amylase variants
02/10/2010EP2151493A1 Host cells containing multiple integrating vectors
02/10/2010EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
02/10/2010EP2151448A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof
02/10/2010EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor
02/10/2010EP2150624A1 Raccoon poxvirus expressing rabies glycoproteins
02/10/2010EP2150618A1 Il-12 immunotherapy for cancer
02/10/2010EP2150617A1 Enhanced expression and stability regions
02/10/2010EP2150616A2 Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
02/10/2010EP2150613A1 Mutant reoviruses and methods of making and using
02/10/2010EP2150561A1 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a
02/10/2010EP2150559A2 Increased production of a target product via stabilization of mrna
02/10/2010EP2150273A2 Modified plasminogen activator inhibitor type-1 molecule and methods based thereon
02/10/2010EP2150100A1 Method for micropropagation of monocots based on sustained totipotent cell cultures
02/10/2010EP1697498B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
02/10/2010EP1532261B1 Methods and dna constructs for high yield production of polypeptides
02/10/2010EP1530637B1 Subtilisin carlsberg proteins with reduced immunogenicity
02/10/2010EP1383924B1 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
02/10/2010EP0910655B1 Vaccines for treatment of lymphoma and leukemia
02/10/2010CN101646774A Cell line having a high transcription activity for the production of proteins, in particular therapeutic proteins
02/10/2010CN101646773A Woody plants having improved growth characteristics and method for making the same
02/10/2010CN101646772A Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
02/10/2010CN101646771A Stabilization of cyclic peptide structures
02/10/2010CN101646770A Enhancement of stress tolerance in plants
02/10/2010CN101646769A Invertebrate micrornas
02/10/2010CN101646768A Attenuated minus-stranded RNA virus
02/10/2010CN101643789A RNA interference mediating small RNA molecules